Gregory D Ayers Selected Research

Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)

1/2019

MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory D Ayers Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 12/2002
11	Melanoma (Melanoma, Malignant) 01/2022 - 01/2010
10	Breast Neoplasms (Breast Cancer) 05/2021 - 03/2006
5	Neoplasm Metastasis (Metastasis) 10/2018 - 03/2006
4	Colorectal Neoplasms (Colorectal Cancer) 09/2014 - 12/2002
3	Colonic Neoplasms (Colon Cancer) 01/2017 - 02/2004
2	Adenocarcinoma 01/2022 - 09/2014
2	Sarcoidosis (Schaumann Disease) 01/2021 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 01/2018
2	Pain (Aches) 05/2019 - 06/2006
2	Hepatoblastoma 06/2013 - 12/2012
2	Vomiting 12/2010 - 03/2009
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 06/2010 - 06/2004
2	Polyps 06/2010 - 06/2004
2	Hand-Foot Syndrome 06/2006 - 12/2002
1	Back Pain (Backache) 01/2021
1	Pulmonary Sarcoidosis 01/2021
1	Shoulder Pain 07/2020
1	Rotator Cuff Injuries 05/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018
1	Rectal Neoplasms (Rectal Cancer) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Polyploidy 10/2017
1	Glioblastoma (Glioblastoma Multiforme) 02/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 06/2015
1	Extranodal Extension 09/2014
1	Virus Diseases (Viral Diseases) 07/2014

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2004
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 03/2014
4	Immune Checkpoint InhibitorsIBA 05/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 06/2004
4	Celecoxib (Celebrex)FDA Link 06/2010 - 12/2002
3	Chemokine ReceptorsIBA 01/2021 - 03/2014
3	NF-kappa B (NF-kB)IBA 09/2012 - 01/2010
2	ChemokinesIBA 06/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 01/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2019
2	LigandsIBA 01/2018 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 01/2013
2	Pharmaceutical PreparationsIBA 10/2017 - 06/2010
2	Phosphotransferases (Kinase)IBA 10/2017 - 12/2014
2	Aurora Kinase AIBA 06/2016 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 12/2014 - 07/2010
2	Messenger RNA (mRNA)IBA 12/2012 - 02/2004
2	Capecitabine (Xeloda)FDA Link 06/2006 - 12/2002
1	avelumabIBA 01/2022
1	AlpelisibIBA 05/2021
1	copanlisibIBA 05/2021
1	gedatolisibIBA 05/2021
1	Opiate AlkaloidsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	trametinibIBA 01/2021
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2021
1	Anti-Idiotypic AntibodiesIBA 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	dabrafenibIBA 01/2021
1	Rifabutin (Ansamycin)FDA Link 01/2021
1	CholesterolIBA 11/2020
1	PhosphoproteinsIBA 01/2020
1	Cyclin D1IBA 01/2019
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	venetoclaxIBA 12/2018
1	Peptides (Polypeptides)IBA 10/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	STA 9090IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2017
1	Granzymes (Granzyme)IBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	NVP-BKM120IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	RNA (Ribonucleic Acid)IBA 06/2016
1	Valganciclovir FDA Link 02/2016
1	Bevacizumab (Avastin)FDA Link 02/2016
1	IpilimumabIBA 03/2015
1	Interleukin-2 (IL2)IBA 03/2015
1	B7-H1 AntigenIBA 03/2015
1	Aurora KinasesIBA 01/2015
1	Histocompatibility Antigens Class IIIBA 12/2014
1	Chemokine CCL11IBA 12/2014
1	Protein Isoforms (Isoforms)IBA 07/2014
1	Zinc Finger E-box-Binding Homeobox 1IBA 05/2014
1	Indicators and Reagents (Reagents)IBA 04/2014

Therapy/Procedure

19	Therapeutics 01/2022 - 04/2006
4	Neoadjuvant Therapy 09/2014 - 06/2013
3	Drug Therapy (Chemotherapy) 01/2018 - 12/2002
2	Immunotherapy 01/2021 - 06/2016
1	Aftercare (After-Treatment) 07/2020
1	Physical Therapy Modalities (Physical Therapy Technique) 05/2019
1	Minimally Invasive Surgical Procedures 01/2018
1	Combined Modality Therapy 01/2018
1	Operative Surgical Procedures 06/2015